Next-Generation Sequencing and Real-Time Quantitative PCR for Minimal Residual Disease (MRD) Detection Using the Immunoglobulin Heavy Chain Variable Region: A Methodical Comparison in Acute Lymphoblastic Leukemia (ALL), Mantle Cell Lymphoma (MCL) and Multiple Myeloma (MM)
Marco Ladetto(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Christiane Pott(University Hospital Schleswig-Holstein), Luigia Monitillo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), François Pépin, Heiko Trautmann(Franklin University), Daniela Drandi(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Simone Ferrero(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Monika Brüggemann(University Hospital Schleswig-Holstein), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Antonio Palumbo(Azienda Ospedaliero Universitaria San Giovanni Battista), Malek Faham, Victoria Carlton, Mario Boccadoro(University of Turin)
Cited by 6
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k